Volume : 08, Issue : 12, December – 2021
Title:
26.HAEMATOPOIETIC STEM CELL TRANSPLANTATION, FROM ITS EARLY STAGES TO TILL DATE
Authors :
Dr. Nithish Sattoju, Dr. Anvesh Maram, Dr. Prashanth Tholkatta , Dr. Vijaykanth Lavudi , Dr. E. Jagadish Kumar
Abstract :
Formation or development of a new cell or an entire human being requires an actively diving cell, which we refer as Stem Cell. By discovering the potency of a stem cell in forming new cells, tissues & organs, the thought of application or use of stem cells in treating various irreversible tissue/ organ damages came out. Different stem cells are responsible in producing different tissues/ organs. With the advent that the stem cells do exist in the adults & can be extracted specifically, various stem cell transplantations took over in treating lethal diseases like cancer, diabetes, etc. The process of stem cell therapy & its applications in various fields of medical sciences is lot to be known. The current study provides a detailed glance on various aspects of one of the majorly studied/ known stem cell transplantations, Haematopoietic Stem Cell Transplantation.
Key Words: Haematopoietic stem cell transplantation; Stem Cells; Irreversible tissue/ organ damage; Autologous S.C.T.; Allogenic S.C.T.; Bone Marrow Transplantation; Peripheral Blood Stem Cell Transplantation; Immuno-phenotyping; Stem Cell Mobilisation.
Cite This Article:
Please cite this article in press Nithish Sattoju et al, Haematopoietic Stem Cell Transplantation, From Its Early Stages To Till Date., Indo Am. J. P. Sci, 2021; 08(12).
Number of Downloads : 10
References:
1. Sudhakar A. History of Cancer, Ancient and Modern Treatment Methods. Journal of cancer science & therapy. 2009 Dec;1(2):1-4.
2. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. nature. 2001 Nov;414(6859):105-11.
3. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science. 2000 Feb 25;287(5457):1442-6.
4. Energy A. Facts and statistics. Last modified. 2013 Sep.
5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer journal for clinicians. 2019 Jan;69(1):7-34.
6. Loukogeorgakis SP, De Coppi P. Stem cells from amniotic fluid–Potential for regenerative medicine. Best practice & research Clinical obstetrics & gynaecology. 2016 Feb 1;31:45-57.
7. Ramasamy TS, Velaithan V, Yeow Y, Sarkar FH. Stem cells derived from amniotic fluid: a potential pluripotent-like cell source for cellular therapy?. Current stem cell research & therapy. 2018 May 1;13(4):252-64.
8. Tuch BE. Stem cells: a clinical update. Australian family physician. 2006 Sep;35(9):719.
9. Thomas ED, Lochte Jr HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. New England Journal of Medicine. 1957 Sep 12;257(11):491-6.
10. Henig I, Zuckerman T. Hematopoietic stem cell transplantation—50 years of evolution and future perspectives. Rambam Maimonides medical journal. 2014 Oct;5(4).
11. Gratwohl A, Niederwieser D. History of hematopoietic stem cell transplantation: evolution and perspectives. InTransplantation Dermatology 2012 (Vol. 43, pp. 81-90). Karger Publishers.
12. Hequet O. Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility. Journal of blood medicine. 2015;6:55.
13. Boyer M, Townsend LE, Vogel LM, Falk J, Reitz-Vick D, Trevor KT, Villalba M, Bendick PJ, Glover JL. Isolation of endothelial cells and their progenitor cells from human peripheral blood. Journal of vascular surgery. 2000 Jan 1;31(1):181-9.
14. Yosupov N, Haimov H, Juodzbalys G. Mobilization, isolation and characterization of stem cells from peripheral blood: a systematic review. Journal of oral & maxillofacial research. 2017 Jan;8(1).
15. BENDER JG, To LB, WILLIAMS S, SCHWARTZBERG LS. Defining a therapeutic dose of peripheral blood stem cells. Journal of hematotherapy. 1992;1(4):329-41.
16. Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem cell research & therapy. 2019 Dec;10(1):1-22.
17. Jenq RR, Van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nature Reviews Cancer. 2010 Mar;10(3):213-21.
18. Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, Threlfall WJ. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer: I. Basal cell carcinoma. Archives of dermatology. 1995 Feb 1;131(2):157-63.
19. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiology and Prevention Biomarkers. 1995 Mar 1;4(2):85-92.
20. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral oncology. 2001 Jul 1;37(5):401-18.
21. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, Zenebergh A, Maes P, Dhooge C, Benoit Y, Beguin Y. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone marrow transplantation. 1998 Jul;22(1):1-6.
22. Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. The Lancet Neurology. 2008 Jul 1;7(7):626-36.
23. Swart JF, Delemarre EM, Van Wijk F, Boelens JJ, Kuball J, Van Laar JM, Wulffraat NM. Haematopoietic stem cell transplantation for autoimmune diseases. Nature Reviews Rheumatology. 2017 Apr;13(4):244-56.
24. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. The Lancet. 2009 May 2;373(9674):1550-61.